ArticleThe American journal of bioethics : AJOB2013
What should be disclosed to research participants?
Article in The American journal of bioethics : AJOB, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Exploring the ethics of tuberculosis human challenge models.Journal of medical ethics · 2026Article
- What information and the extent of information to be provided in an informed assent/consent form of pediatric drug trials.BMC medical ethics · 2022Article
- Comparing Smoking Cessation Interventions among Underserved Patients Referred for Lung Cancer Screening: A Pragmatic Trial Protocol.Annals of the American Thoracic Society · 2022Article
- Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease.International journal of clinical practice · 2021Article
- Details of risk-benefit communication in informed consent documents for phase I/II trials.Clinical trials (London, England) · 2021Article
- Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers.European journal of clinical pharmacology · 2019Article
- What information and the extent of information research participants need in informed consent forms: a multi-country survey.BMC medical ethics · 2018Article
- Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation.BMC medical ethics · 2018Review
- A comparison of institutional review board professionals' and patients' views on consent for research on medical practices.Clinical trials (London, England) · 2016Article
- Patients' Views Concerning Research on Medical Practices: Implications for Consent.AJOB empirical bioethics · 2016Article
- Implications of the concept of minimal risk in research on informed choice in clinical practice.Journal of medical ethics · 2015Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
1 author.
Funding
Abstract
Debate surrounding the SUPPORT study highlights the absence of consensus regarding what information should be disclosed to potential research participants. Some commentators endorse the view that clinical research should be subject to high disclosure standards, even when it is testing standard-of-care interventions. Others argue that trials assessing standard-of-care interventions need to disclose only the information that is disclosed in the clinical care setting. To resolve this debate, it is important to identify the ethical concerns raised by clinical research and determine what consent process is needed to address them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.